GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3

LONA financial changes

Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.

Search securities →
LONALeonaBio, Inc.
MEDIUM IMPORTANCER And DR And D Acceleration100TH HISTORICAL PCTL

Research & development increased 247.0%

Research & development changed +247.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.

$3.7M$12.7M3 prior comparisons

Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.